Original Literature | Model OverView |
---|---|
Publication
Title
Innate immune sensing of pathogens and danger signals by cell surface Toll-likereceptors.
Affiliation
Division of Infectious Genetics, The Institute of Medical Science, TheUniversity of Tokyo, Japan. kmiyake@ims.u-tokyo.ac.jp
Abstract
The Toll family of receptors consists of cell surface TLRs (TLR4/MD-2, TLR1,TLR2, and TLR6) and intracellular TLRs (TLR3, TLR7, TLR8, and TLR9). Cellsurface TLRs sense microbial membranes such as lipopolysaccharide orlipopeptides. Recognition by TLRs is the frontline where pathogens and a hosttry to take the control of immune responses. Bacteria can modulate the structureof a TLR ligand lipid A to subvert host responses. Cell surface TLRs also senseendogenous ligands which are released in tissue damages as danger signals andinduce inflammation in infectious and non-infectious condition. The availabilityof endogenous ligands and the amount of cell surface TLRs are both tightlylimited to keep TLR responses sufficient for containment of pathogens withoutdetrimental responses to the host.
PMID
17275324
|
Entity
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m14
10
infinite
0
TRANSPATH | MO000000058 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
LPS:LBP:CD14
--
MO000021929
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6255
10
infinite
0
TRANSPATH | MO000021929 |
--
csml-variable:Double
m6500
10
infinite
0
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
LPS:LBP:CD14:TLR4{oligomer}:MD2
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
LPS:MD-2
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
LPS:LBP:CD14:TLR4{oligomer}:MD2:MyD88:TIRAP
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
NF-kappaB{active}
--
e14
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m15
10
infinite
0
TRANSPATH | MO000000058 |
--
pro-inflammatory cytokines
--
e15
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m16
0
infinite
0
--
Pro-inflammtory cytokies
--
e16
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m17
0
infinite
0
--
LPS:LBP:CD14:TLR4{oligomer}:MD2:TRIF:TRAM
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
IRF-3{p}:IRF-3{p}
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
TLR2:TLR6
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
triacylated lipopeptide
--
e20
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
Triacylated lipopeptide:TLR2:TLR6
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
TLR2:TLR1
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
CD36
--
e23
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
TLR2:TLR1:CD14
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
TLR2:TLR1:CD36
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
Diacylated lipopeptide
--
e26
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m27
0
infinite
0
--
TLR2:TLR1:CD14:Di acylated lipopeptide
--
e27
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m28
0
infinite
0
--
TLR2:TLR1:CD36:Di acylated lipopeptide
--
e28
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m29
0
infinite
0
--
Lipoteichoic acid
--
e29
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
TLR2:TLR1:CD14:Lipoteichoic acid
--
e30
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m31
0
infinite
0
--
TLR2:TLR1:CD36:Lipoteichoic acid
--
e31
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m32
0
infinite
0
--
--
e32
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m33
0
infinite
0
--
--
e33
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m34
0
infinite
0
--
--
e34
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m35
0
infinite
0
--
A/D type CpG
--
e35
cso30:c:Dna
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m36
0
infinite
0
--
A/D type CpG:TLR9
--
e36
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m37
0
infinite
0
--
--
e37
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Lysosome
--
--
--
csml-variable:Double
m38
0
infinite
0
--
--
e38
cso30:c:EntityBiologicalCompartment
cso30:i:CC_LysosomalLumen
--
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e39
cso30:c:EntityBiologicalCompartment
cso30:i:CC_LysosomalMembrane
--
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
B/K type CpG
--
e41
cso30:c:Dna
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m42
0
infinite
0
--
B/K type CpG: TLR9
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
RP105:MD-1
--
e43
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m44
0
infinite
0
--
RP105:MD-1:TLR4:MD-2
--
e44
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m45
0
infinite
0
--
NO
--
e45
cso30:c:SmallMolecule
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m46
0
infinite
0
--
--
e46
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
--
--
csml-variable:Double
m47
0
infinite
0
--
--
e47
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum
--
--
--
csml-variable:Double
m48
0
infinite
0
--
--
e48
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulumLumen
--
--
--
csml-variable:Double
m49
0
infinite
0
--
--
e49
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToExternalSideOfMembrane_
--
--
--
csml-variable:Double
m63
0
infinite
0
--
TLR4:MD2
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LPS:LBP:CD14:TLR4:MD2
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e63
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_Membrane_
--
--
--
csml-variable:Double
m64
0
infinite
0
--
--
e64
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
--
--
csml-variable:Double
m65
0
infinite
0
--
gp96
--
e65
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m66
0
infinite
0
--
pr0-inflammtory cytokines
--
e66
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m67
0
infinite
0
--
Co-stimulatory molecules
--
e67
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m68
0
infinite
0
--
TLR4:gp96
--
e69
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
Biglycan
--
e70
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m71
0
infinite
0
--
TLR4:MD-2:Biglycan
--
e71
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m72
0
infinite
0
--
TLR2:TLR6:Biglycan
--
e72
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m73
0
infinite
0
--
csml-variable:Double
m74
0
infinite
0
--
p38{active}
--
e74
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m75
0
infinite
0
--
ERK
--
e75
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m76
0
infinite
0
--
ERK{active}
--
e76
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m77
0
infinite
0
--
MIP-2
--
e77
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m78
0
infinite
0
--
CD14:TLR4:MD-2
--
e78
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m79
0
infinite
0
--
CD14:TLR4:MD-2:Biglycan
--
e79
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
Cellular fibronectin
--
e80
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m81
0
infinite
0
--
MMP-9
--
e81
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m82
0
infinite
0
--
SP-A
--
e83
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m84
0
infinite
0
--
IL-10
--
e84
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m85
0
infinite
0
--
IL-10
--
e85
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m86
0
infinite
0
--
HMGB1
--
e86
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m87
0
infinite
0
--
TLR4:MD-2:HMGB1
--
e87
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m88
0
infinite
0
--
HMGB1:TLR2:TLR6
--
e88
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m89
0
infinite
0
--
OxLDL
--
e89
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m90
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
Actin
--
e90
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m91
0
infinite
0
--
csml-variable:Double
m92
0
infinite
0
--
mDF2beta
--
e92
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m93
0
infinite
0
--
TLR4;MD-2:mDFbeta
--
e93
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m94
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m3985*m155666*0.1
nodelay
--
0
PMID: 17275324 LBP is thought to be a shuttle protein catalyzing LPS transfer from the outer membrane of Gram-negative bacteria to CD14, another LPS binding molecule.
p10
p10
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m18*m977*0.1
nodelay
--
0
PMID: 17275324 A second set of adaptor molecules, TIR domain-containing adapter inducing interferon-beta (TRIF)/TIR domain-containing adapter molecule-1 (TICAM-1) and TRIF-related adapter molecule (TRAM)/TIR domain-containing adapter molecule- 2 (TICAM-2), are required for LPS-induced phosphorylation and dimerization of the transcription factor IRF-3, leading to interferon-beta (IFN-beta) production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m19324*0.1
nodelay
--
0
PMID: 17275324 A second set of adaptor molecules, TIR domain-containing adapter inducing interferon-beta (TRIF)/TIR domain-containing adapter molecule-1 (TICAM-1) and TRIF-related adapter molecule (TRAM)/TIR domain-containing adapter molecule- 2 (TICAM-2), are required for LPS-induced phosphorylation and dimerization of the transcription factor IRF-3, leading to interferon-beta (IFN-beta) production PMID: 17275324 Figure 1
p12
p12
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m93217*m19*0.1
nodelay
--
0
PMID: 17275324 A second set of adaptor molecules, TIR domain-containing adapter inducing interferon-beta (TRIF)/TIR domain-containing adapter molecule-1 (TICAM-1) and TRIF-related adapter molecule (TRAM)/TIR domain-containing adapter molecule- 2 (TICAM-2), are required for LPS-induced phosphorylation and dimerization of the transcription factor IRF-3, leading to interferon-beta (IFN-beta) production PMID: 17275324 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m20*m21*0.1
nodelay
--
0
PMID: 17275324 Tricacylated lipopeptide is recognized by TLR1/TLR2, whereas diacylated lipopeptide is sensed by TLR2/TLR6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m23*m2828*0.1
nodelay
--
0
PMID: 17275324,15895089,15690042 CD14 is required for diacylated lipopeptides and lipoteichoic acid whereas forward genetics revealed thatCD36 is another accessory molecule for TLR2 in its response to diacylated lipopeptide and lipoteichoic acid
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m23*m24*0.1
nodelay
--
0
PMID: 17275324,15895089,15690042 CD14 is required for diacylated lipopeptides and lipoteichoic acid whereas forward genetics revealed thatCD36 is another accessory molecule for TLR2 in its response to diacylated lipopeptide and lipoteichoic acid
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m25*m27*0.1
nodelay
--
0
PMID: 17275324,15895089,15690042 CD14 is required for diacylated lipopeptides and lipoteichoic acid whereas forward genetics revealed thatCD36 is another accessory molecule for TLR2 in its response to diacylated lipopeptide and lipoteichoic acid
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m26*m27*0.1
nodelay
--
0
PMID: 17275324,15895089,15690042 CD14 is required for diacylated lipopeptides and lipoteichoic acid whereas forward genetics revealed thatCD36 is another accessory molecule for TLR2 in its response to diacylated lipopeptide and lipoteichoic acid
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m25*m30*0.1
nodelay
--
0
PMID: 17275324,15895089,15690042 CD14 is required for diacylated lipopeptides and lipoteichoic acid whereas forward genetics revealed thatCD36 is another accessory molecule for TLR2 in its response to diacylated lipopeptide and lipoteichoic acid
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m26*m30*0.1
nodelay
--
0
PMID: 17275324,15895089,15690042 CD14 is required for diacylated lipopeptides and lipoteichoic acid whereas forward genetics revealed thatCD36 is another accessory molecule for TLR2 in its response to diacylated lipopeptide and lipoteichoic acid
p1
p2
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m6254*m2828*0.1
nodelay
--
0
PMID: 17275324 LBP is thought to be a shuttle protein catalyzing LPS transfer from the outer membrane of Gram-negative bacteria to CD14, another LPS binding molecule.
p20
p20
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m36*m19828*0.1
nodelay
--
0
PMID: 17275324 A/D-type CpG is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the complex consisting of downstream signaling molecules, whereas the B/K-type CpG. is recognized by TLR9 in the lysosome.
p20
p21
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m42*m41*0.1
nodelay
--
0
PMID: 17275324 A/D-type CpG is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the complex consisting of downstream signaling molecules, whereas the B/K-type CpG. is recognized by TLR9 in the lysosome.
p22
p22
cso30:i:ME_Glycosylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m3961*m6438*0.1
nodelay
--
0
PMID: 17275324 The LPS coreceptor MD-2 was also shown to facilitate glycosylation and cell surface expression of TLR4.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m1632*m6500*0.1
nodelay
--
0
PMID: 17275324,7897216 Radioprotective 105 (RP105) is most similar to TLR4 in extracellular leucine-rich repeats than other members of the Toll family, and forms a complex with MD-1, cloning of which led to the cloning of MD-2 as a molecule similar to MD-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m44*m5*0.1
nodelay
--
0
PMID: 17275324,15852007 A molecular mechanism by which RP105/MD-1 contribute to B cell responses to TLR4/MD-2 and TLR2 ligands was suggested by a recent report demonstrating that RP105/MD-1 is associated with TLR4/MD-2
p25
p25
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c79 : 1
stoichiometry:c75 : 1
m4645*m93309*m11*0.1
nodelay
--
0
PMID: 17275324,10623794,11402040 HSP60-dependent induction of TNF-alpha and NO in macrophages was dependent on TLR4 signaling
p25
p26
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c80 : 1
stoichiometry:c78 : 1
m4645*m93479*m11*0.1
nodelay
--
0
PMID: 17275324,10623794,11402040 HSP60-dependent induction of TNF-alpha and NO in macrophages was dependent on TLR4 signaling
p27
p27
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m5956*m93589*0.1
nodelay
--
0
PMID: 17275324,11842086 HSP70 induces interleukin-12 (IL-12) production in macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m66*m16*0.1
nodelay
--
0
PMID: 17275324,11912201 An ER chaperone gp96 induces production of proinflammatory cytokines and upregulation of co-stimulatory molecules in bone marrow DCs from wild type mice, whereas DCs from TLR4 mutant or TLR4/TLR2 double mutant mice failed to respond to gp96
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m66*0.1
nodelay
--
0
PMID: 17275324,11912201 An ER chaperone gp96 induces production of proinflammatory cytokines and upregulation of co-stimulatory molecules in bone marrow DCs from wild type mice, whereas DCs from TLR4 mutant or TLR4/TLR2 double mutant mice failed to respond to gp96
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c136 : 1
stoichiometry:c9 : 1
m6255*m5*m81*0.1
nodelay
--
0
PMID: 17275324 CD14 has a role in loading LPS to the receptor complex consisting of TLR4 and MD-2. PMID: 17275324,11150311 Recombinant EDA, but not other recombinant fibronectin domains, induces expression of a matrix methalloproteinase MMP-9 in human macrophages by stimulating TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m69*m66*0.1
nodelay
--
0
PMID: 17275324 An ER chaperon gp96 is associated with TLR4 in ER and required for cell surface expression of TLR4
p31
p31
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m93614*m66*0.1
nodelay
--
0
PMID: 17275324 An ER chaperon gp96 is associated with TLR4 in ER and required for cell surface expression of TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m71*m5*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m71*m20*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m72*m74*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m73*m74*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
p34
p36
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m72*m14*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
p34
p37
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m73*m14*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m72*m76*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m73*m76*0.1
nodelay
--
0
PMID: 17275324 Biglycan, a small leucine-rich proteoglycan in ECM component, acts on macrophages as an endogenous ligand of TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-KappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m6*0.1
nodelay
--
0
PMID: 17275324 LPS is similar to a cytokine in that it interacts with a receptor TLR4/MD-2, and induces oligomerization of TLR4, leading to activation of downstream signaling pathways by recruiting downstream adaptor molecules
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m75*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
m15*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m77*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m77*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m15*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m75*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m3961*m71*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
stoichiometry:c135 : 1
m71*m79*0.1
nodelay
--
0
PMID: 17275324 Moreover, biglycan was shown to be physically associated with CD14/TLR4/MD-2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c137 : 1
m6*0.1
nodelay
--
0
PMID: 17275324,11150311 Recombinant EDA, but not other recombinant fibronectin domains, induces expression of a matrix methalloproteinase MMP-9 in human macrophages by stimulating TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m84*m6255*m5*0.1
nodelay
--
0
PMID: 17275324 CD14 has a role in loading LPS to the receptor complex consisting of TLR4 and MD-2. PMID: 17275324,12055204 SP-A induces NF-KappaB activation and cytokine production such as TNF-alpha and IL-10 in macrophages by stimulating TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m155666*m6438*0.1
nodelay
--
0
PMID: 17275324,15557191,15010525,11521076 Direct interaction between LPS and purified MD-2 without TLR4 was also reported whereas the direct interaction between TLR4 and LPS has not been demonstrated.
p50
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c144 : 1
stoichiometry:c145 : 1
m6*m14*0.1
nodelay
--
0
PMID: 17275324,12055204 SP-A induces NF-KappaB activation and cytokine production such as TNF-alpha and IL-10 in macrophages by stimulating TLR4
p51
p51
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c147 : 1
stoichiometry:c148 : 1
m15*m93309*0.1
nodelay
--
0
PMID: 17275324,12055204 SP-A induces NF-KappaB activation and cytokine production such as TNF-alpha and IL-10 in macrophages by stimulating TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c151 : 1
stoichiometry:c150 : 1
m85*m15*0.1
nodelay
--
0
PMID: 17275324,12055204 SP-A induces NF-KappaB activation and cytokine production such as TNF-alpha and IL-10 in macrophages by stimulating TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m87*m5*0.1
nodelay
--
0
PMID: 17275324,15795240 High-mobility group box 1 (HMGB1) was identified as an endogenous ligand for TLR4/MD-2 and TLR2 that serves as a late mediator of lethality in sepsis and as an early mediator of inflammation and organ damage in hepatic ischemia reperfusion injury, a pathophysiologic process whereby hypoxic organ damage is accentuated following return of blood flow and oxygen delivery
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m87*m20*0.1
nodelay
--
0
PMID: 17275324,15795240 High-mobility group box 1 (HMGB1) was identified as an endogenous ligand for TLR4/MD-2 and TLR2 that serves as a late mediator of lethality in sepsis and as an early mediator of inflammation and organ damage in hepatic ischemia reperfusion injury, a pathophysiologic process whereby hypoxic organ damage is accentuated following return of blood flow and oxygen delivery
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c159 : 1
stoichiometry:c161 : 1
stoichiometry:c160 : 1
m90*m91*m5*0.1
nodelay
--
0
PMID: 17275324 Oxidized low-density lipoprotein (OxLDL) induces actin polymerization and spreading of macrophages, which results in pro-atherogenic consequences as inhibition of phagocytosis of apoptotic cells but enhancement of OxLDL uptake. PMID: 17275324,12424240 This effect is mediated by TLR4/MD-2 but not by TLR2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
stoichiometry:c164 : 1
m5*m93*0.1
nodelay
--
0
PMID: 17275324,12411706 Beta-Defensins are small antimicrobial peptides of the innate immune system produced in response to microbial infection of mucosal tissue and skin. Murine beta-defensin 2 (mDF2beta) acts directly on immature dendritic cells as an endogenous ligand for TLR4, inducing upregulation of co-stimulatory molecules and dendritic cell maturation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c165 : 1
m94*0.1
nodelay
--
0
PMID: 17275324,12411706 Beta-Defensins are small antimicrobial peptides of the innate immune system produced in response to microbial infection of mucosal tissue and skin. Murine beta-defensin 2 (mDF2beta) acts directly on immature dendritic cells as an endogenous ligand for TLR4, inducing upregulation of co-stimulatory molecules and dendritic cell maturation
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c18 : 1
stoichiometry:c17 : 1
m11*m1572*m6810*0.1
nodelay
--
0
PMID: 17275324 Figure 1 PMID: 17275324 ¡ÆMyD88-dependent¡Ç pathway, requires two adaptor molecules, myeloid differentiation factor 88 (MyD88) and MyD88 adapterlike (Mal)/TIR domain-containing protein (TIRAP), and leads to early activation of the transcription factor NF-KappaB, the production of proinflammatory cytokines, and Th1 responses.
p7
p7
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m13*m14*0.1
nodelay
--
0
PMID: 17275324 Figure 1 PMID: 17275324 ¡ÆMyD88-dependent¡Ç pathway, requires two adaptor molecules, myeloid differentiation factor 88 (MyD88) and MyD88 adapterlike (Mal)/TIR domain-containing protein (TIRAP), and leads to early activation of the transcription factor NF-KappaB, the production of proinflammatory cytokines, and Th1 responses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m15*m16*0.1
nodelay
--
0
PMID: 17275324 Figure 1 PMID: 17275324 ¡ÆMyD88-dependent¡Ç pathway, requires two adaptor molecules, myeloid differentiation factor 88 (MyD88) and MyD88 adapterlike (Mal)/TIR domain-containing protein (TIRAP), and leads to early activation of the transcription factor NF-kappaB, the production of proinflammatory cytokines, and Th1 responses.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m11*m18998*m19005*0.1
nodelay
--
0
PMID: 17275324 Figure 1 PMID: 17275324 A second set of adaptor molecules, TIR domain-containing adapter inducing interferon-beta (TRIF)/TIR domain-containing adapter molecule-1 (TICAM-1) and TRIF-related adapter molecule (TRAM)/TIR domain-containing adapter molecule- 2 (TICAM-2), are required for LPS-induced phosphorylation and dimerization of the transcription factor IRF-3, leading to interferon-beta (IFN-beta) production
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--